Navigation Links
Study Suggests Strattera Improved ADHD Symptoms in Patients With,Comorbid Alcohol Abuse

itable moods while taking Strattera, you should report them to your child's doctor right away.

For male patients, if you are taking Strattera and experience priapism, a painful or prolonged erection lasting more than four hours, call your doctor right away. As with all ADHD medications, growth should be monitored during treatment, although height and weight data measured for up to three years indicates minimal, if any, long-term effects.

Most people in clinical studies who experienced side effects were not bothered enough to stop using Strattera. The most common side effects in children and adolescents in medical studies were upset stomach, decreased appetite, nausea and vomiting, dizziness, tiredness and mood swings. In adults, the most common side effects were constipation, dry mouth, nausea, decreased appetite, dizziness, problems sleeping, sexual side effects, problems urinating and menstrual cramps.

For Medication Guide, visit www.Strattera.com.

For full Prescribing Information, including Boxed Warning information, visit http://www.Strattera.com/.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers -- through medicines and information -- for some of the world's most urgent medical needs. Additional information about Lilly is available at www.lilly.com.

P-LLY

This press release contains forward-looking statements about Strattera for the treatment of ADHD and reflects Lilly's current beliefs. However, as with any pharmaceutical product, ther
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
2. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
3. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. Reaction to Avandia Warnings Stronger Among Internists Than Endocrinologists, According to Study by GfK Market Measures
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
8. Protox Announces Positive Clinical Data from Prostate Cancer Study
9. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
10. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
Post Your Comments:
(Date:8/19/2008)...EGO, Aug. 19 /- Vical Incor...h collaboration with the Karolinska,Institute, a l...h Institute,for Infectious Disease Control (SMI), ...Vaxfectin(R) adjuvant with the Biojector(R) 2000,n...ologies Inc.,OTCBB:BJCT) for a multivalent preven...
(Date:8/18/2008)...findings offer hope for increased life expectancy ...8 /PRNewswire-USNewswire/ -- In the world of Down,... progress has been,tracked for the past 16 years, ... life expectancy of a person with Down syndrome, c...n ,Mr. C, was born. Further, ,Mr. C, does,not exhi...
(Date:8/18/2008)... - Clinical trial currently in Phase I -, .../ -- Tobira,Therapeutics Inc., a clinical stage bi...product discovery against life-threatening and lif...e issuance of Patent No. 7,371,772,B2 by the U.S. ...BR-652, a,CCR5 antagonist currently in Phase I dev...
(Date:8/14/2008)...ORE, Aug. 15 /- AstraZeneca...artnership with the National Cancer,Centre Singapo...H) to,develop anti-cancer compounds. The collabora...tanding (MOU) that was signed today, aims to furth...es in Asia and ultimately,speed up access to new m...
Breaking Medicine Technology:Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 2Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 3Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 4Karolinska Institute to Test Vical's Vaxfectin(R) Adjuvant with Preventive Vaccine against HIV Under Sponsorship of Swedish Institute for Infectious Disease Control 5Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 2Seventy Years Old and Going Strong With Down Syndrome and No Dementia: The Case of 'Mr. C' Causes Major Interest in the Scientific Community 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6Software Techniques Inc Selects M2SYS Fingerprint Software to Meet Continuous Growth and Demand for Desktop Biometric Time 26 Attendance Solutions 1357 1Software Techniques Inc Selects M2SYS Fingerprint Software to Meet Continuous Growth and Demand for Desktop Biometric Time 26 Attendance Solutions 1357 2High Q NIST nanowires may be practical oscillators 1973 1High Q NIST nanowires may be practical oscillators 1973 2Will Rogers Institute to Honor Worlds Leading Geneticist and Recent Medal of Freedom Recipient Dr Francis S Collins For His Outstanding Contributio 7061 1Will Rogers Institute to Honor Worlds Leading Geneticist and Recent Medal of Freedom Recipient Dr Francis S Collins For His Outstanding Contributio 7061 2Viramontes to Lead PPD Clinical Operations in Mexico Central America and the Caribbean 1971 1Viramontes to Lead PPD Clinical Operations in Mexico Central America and the Caribbean 1971 2Viramontes to Lead PPD Clinical Operations in Mexico Central America and the Caribbean 1971 3
(Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
(Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
(Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
(Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
... has offered invaluable advice to women of childbe...ultivitamin daily, to cut the risks of delivering ...has indicated that by being regular with intake of...ny severe birth defects can be offset. The defects...
...dents are unprepared for skilled prescribing, warn...ribing in the UK is abundant, write Jeffrey Aronso... underprescribed and prescription errors are commo...ork in hospitals. The reasons for these errors a...
...etes in pregnancy has increased four times among A...cerns that gestational diabetes// may cause proble...ent in the last five years. Diabetes Australia NSW...a dangerous precedent. "In just five years we hav...
...University of South Florida College of Medicine sa... Florida is discouraging medical students// from o...alization. The situation means that many people do...Deutsch, MD, lead author of the study and chief re...
Other Medicine News:Health News:Many Medical Students Unprepared for Skilled Prescribing 2Health News:Malpractice Worry Discouraging Medical Students From Taking Up Obstetrics And Gynecology 2
Inquire
...yles. Each style has multiple sizes. Style 1 is by... available non-sterile and sterile, and are packag...s are mirror-image meaning that they are each made... normally inserted through a transaxillary (armpit...
...vivo results may be affected by the thickness of t...on scar tissue can impact the desired augment-atio...from patient to patient. Implant dimensions can be... scissors. All dimensions in centimeters. This dev...
...Qmark family elevates your ECG and Spirometry capa...ity, cost-savings and efficient patient care. The ...in the office, clinics and medical centers as well...en used in conjunction with the IQmark Digital ECG...
Medicine Products: